Pharma & HealthcareTop Companies
Pharma & Healthcare

Top C-Arms Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Pharma & Healthcare

Published

Feb 2026

Share:

Pharma & Healthcare

Top C-Arms Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
2.18 Billion
2026 Forecast (US$)
2.28 Billion
2032 Forecast (US$)
3.03 Billion
CAGR (2025-2032)
4.80%

Summary

The global C-Arms market is in a steady expansion phase, supported by surgical volume growth, outpatient migration, and demand for radiation-safe, workflow-efficient imaging. A concentrated group of C-Arms market companies dominates installed base and innovation. The sector is projected to grow from US$ 2.18 Billion in 2025 to US$ 3.03 Billion by 2032, at a 4.80% CAGR.

2025 Revenue of Top C-Arms Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

The ranking of C-Arms market companies is based on a composite scoring framework that blends quantitative and qualitative factors. Core inputs include estimated 2025 C-Arms revenue, growth versus the market, and global installed base across hospitals, ambulatory surgery centers, and specialty clinics. We also evaluate win-rates in large tenders, breadth of fixed versus mobile C-arm portfolios, and depth of clinical applications such as orthopedics, cardiovascular, and pain management. Technology differentiation is assessed through detector and imaging chain performance, dose-optimization features, software intelligence, and integration with surgical navigation or robotics platforms. Service coverage, uptime guarantees, and capacity to execute multi-year maintenance and managed-service contracts are key weighting factors. Each criterion is normalized to a 0–10 scale, with revenue, technology, and service capabilities receiving higher weights, and final rankings reflecting the aggregate score.

Top 10 Companies in C-Arms

1
Siemens Healthineers AG
Strong installed base in Europe and North America; rapidly growing in Asia-Pacific.
Artis zee, Artis Q, Cios Alpha, Cios Spin
Hybrid OR C-arms, cardiovascular labs, advanced 3D imaging for surgery and interventional radiology.
Erlangen, Germany
Market leader in high-end fixed and mobile C-arms with strong penetration in tertiary hospitals.
Expanded image-guided therapy portfolio, AI-enabled dose reduction, and OR integration partnerships.
US$ 620.00 Million
2
GE HealthCare Technologies Inc.
Strong U.S. leadership and growing footprint in Latin America and the Middle East.
OEC 9900 Elite, OEC One CFD, OEC 3D
Mobile C-arms for surgery, pain management, orthopedics, and vascular procedures.
Chicago, USA
Top-tier player with balanced presence in premium and mid-range mobile C-arms.
Investing in CMOS flat-panel detectors and advanced visualization; expanding ASCs-focused offerings.
US$ 540.00 Million
3
Philips Healthcare (Royal Philips)
High share in Western Europe and advanced hospitals globally.
Azurion, Zenition series
Fixed C-arms for cardiology, oncology, and neuro interventions; mobile C-arm portfolio expanding.
Best, Netherlands
Leader in interventional labs and hybrid ORs with integrated C-arm solutions.
Strengthening image-guided therapy ecosystem and cloud-connected workflow platforms.
US$ 410.00 Million
4
Canon Medical Systems Corporation
Leverages wider Canon imaging ecosystem and installed base.
Alphenix series
Angio suites, hybrid OR C-arms, selective mobile C-arm offerings.
Tochigi, Japan
Strong niche in interventional radiology and cardiology systems.
Focusing on dose efficiency, 3D imaging, and expansion in Asia-Pacific.
US$ 210.00 Million
5
Ziehm Imaging GmbH
High innovation focus on compact and flexible systems.
Ziehm Vision, Ziehm Solo, Ziehm RFD
Mobile C-arms for orthopedics, trauma, vascular, and pain procedures.
Nuremberg, Germany
Specialist in mobile C-arms with strong presence in Europe.
Expanding flat-panel portfolio and OEM collaborations in surgery.
US$ 180.00 Million
6
Shimadzu Corporation
Competes strongly in cost-sensitive public tenders.
OPESCOPE series, Trinias
Mobile surgical C-arms, angiography systems.
Kyoto, Japan
Reputable imaging vendor with selective C-arm penetration in Asia and Latin America.
Enhancing ergonomic design and regional channel partners.
US$ 150.00 Million
7
Hologic, Inc.
Niche specialization with strong brand recognition.
Fluoroscan InSight, related mini C-arm platforms
Mini C-arms, extremity imaging, orthopedic clinics.
Marlborough, USA
Focused player in women’s health and extremity imaging C-arm applications.
Targeting outpatient orthopedic and sports medicine centers.
US$ 120.00 Million
8
Allengers Medical Systems Limited
Competitive pricing and strong local service network.
HF C-Arm series, Digitally enhanced variants
Analog and digital mobile C-arms for general surgery and orthopedics.
Chandigarh, India
Leading Indian C-arm vendor with expanding export footprint.
Scaling manufacturing and expanding in Africa, Southeast Asia.
US$ 85.00 Million
9
Medtronic plc (O-arm / imaging segment)
High-value installed base in advanced surgical centers.
O-arm O2 Imaging System
O-arm systems integrated with navigation and robotics.
Dublin, Ireland
Specialist in intraoperative 3D imaging for spine and neurosurgery.
Deep integration with spine robotics and navigation platforms.
US$ 80.00 Million
10
Eurocolumbus s.r.l.
Flexible engineering and tailored configurations for regional hospitals.
Opescope-like C-arm lines, customized models
Mobile C-arms for orthopedics and vascular surgery.
Milan, Italy
Smaller European manufacturer with customized C-arm offerings.
Focusing on OEM partnerships and niche hospital projects.
US$ 45.00 Million

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Siemens Healthineers AG

Global medtech leader with a comprehensive C-arm portfolio spanning hybrid ORs, interventional labs, and sophisticated mobile systems.

Key Financials: 2025 C-Arms revenue US$ 620.00 Million; C-Arms segment growth estimated at 5.10% annually 2025-2032.
Flagship Products: Artis zee, Artis Q, Cios Alpha, Cios Spin
2025-2026 Actions: Expanded AI-enabled imaging software, integrated workflow platforms, and multi-year managed-service contracts with large hospital groups.
Three-line SWOT: Extensive global installed base and service network; Premium pricing can limit adoption in cost-sensitive markets; Opportunity—hybrid OR expansion and robotics-integrated surgery worldwide.
Notable Customers: Cleveland Clinic, Charité Berlin, Apollo Hospitals
2

GE HealthCare Technologies Inc.

Major imaging vendor with strong heritage in surgical mobile C-arms and deep relationships with U.S. hospitals and ASCs.

Key Financials: 2025 C-Arms revenue US$ 540.00 Million; Operating margin in imaging division estimated around 16.50%.
Flagship Products: OEC 9900 Elite, OEC One CFD, OEC 3D
2025-2026 Actions: Launched upgraded CMOS-detector C-arms, tailored ASC bundles, and extended remote monitoring services for uptime.
Three-line SWOT: Strong OEC brand recognition and service; Portfolio gaps in very low-cost segments; Opportunity—ASC proliferation and outpatient spine, pain procedures in developed markets.
Notable Customers: HCA Healthcare, Mayo Clinic, Ramsay Health Care
3

Philips Healthcare (Royal Philips)

Integrated health technology company leading in interventional labs and hybrid OR C-arm platforms with strong software ecosystem.

Key Financials: 2025 C-Arms revenue US$ 410.00 Million; Image-guided therapy business growing about 5.60% CAGR.
Flagship Products: Azurion, Zenition 50, Zenition 70
2025-2026 Actions: Expanded Zenition mobile C-arms, reinforced subscription-based informatics and remote support services.
Three-line SWOT: Deep expertise in interventional cardiology and oncology; Some legacy quality issues impact perception; Opportunity—platform-based upgrades and cloud-connected imaging analytics.
Notable Customers: University Hospital Zürich, Mount Sinai Health System, NHS Trusts UK
4

Canon Medical Systems Corporation

Japanese imaging specialist focused on dose-efficient interventional systems integrated with broader Canon diagnostic portfolio.

Key Financials: 2025 C-Arms revenue US$ 210.00 Million; R&D spend approximately 9.80% of imaging revenues.
Flagship Products: Alphenix Core, Alphenix Hybrid OR, Alphenix Sky
2025-2026 Actions: Enhanced 3D roadmapping, expanded sales alliances in ASEAN, and upgraded flexible financing programs.
Three-line SWOT: Strong dose-optimization technology; Limited brand visibility versus top three in some regions; Opportunity—Asia-Pacific infrastructure and cardiovascular disease burden.
Notable Customers: Singapore General Hospital, St. Luke’s International Hospital, select Brazilian cardiology centers
5

Ziehm Imaging GmbH

Focused C-arm innovator offering compact, high-performance mobile systems with strong adoption in European surgical centers.

Key Financials: 2025 C-Arms revenue US$ 180.00 Million; Mobile C-arm portfolio CAGR expected at 5.20%.
Flagship Products: Ziehm Vision RFD, Ziehm Solo, Ziehm Vision FD
2025-2026 Actions: Introduced enhanced flat-panel models, expanded distribution in North America, and strengthened training programs for surgeons.
Three-line SWOT: High innovation agility in mobile C-arms; Smaller balance sheet than diversified giants; Opportunity—growing orthopedic and trauma surgery volumes globally.
Notable Customers: Helios Kliniken, NHS regional hospitals, private orthopedic chains in Germany
6

Shimadzu Corporation

Established Japanese imaging vendor with competitive C-arm solutions targeting public hospitals and regional medical centers.

Key Financials: 2025 C-Arms revenue US$ 150.00 Million; Imaging systems revenue mix increasingly shifting toward digital platforms.
Flagship Products: OPESCOPE ACTENO, OPESCOPE Pleno, Trinias angiography series
2025-2026 Actions: Improved user ergonomics, upgraded flat-panel options, and developed co-marketing alliances with regional distributors.
Three-line SWOT: Reliable technology and competitive pricing; Limited marketing strength in Western Europe and U.S.; Opportunity—government-backed hospital expansion in Asia and Latin America.
Notable Customers: Japanese public hospitals, Brazilian regional hospitals, Southeast Asian ministries of health
7

Hologic, Inc.

Specialist in women’s health and extremity imaging with a strong niche in mini C-arms for orthopedic applications.

Key Financials: 2025 C-Arms revenue US$ 120.00 Million; Company-wide R&D intensity around 7.90% of sales.
Flagship Products: Fluoroscan InSight FD, Fluoroscan mini C-arm variants
2025-2026 Actions: Targeted marketing to outpatient orthopedic clinics and sports medicine centers; improved dose management features.
Three-line SWOT: Niche leadership in mini C-arms; Limited full-size C-arm offering; Opportunity—growth in ambulatory orthopedic procedures and sports injuries imaging.
Notable Customers: Orthopedic specialty clinics USA, sports medicine centers, regional imaging centers
8

Allengers Medical Systems Limited

Indian manufacturer supplying cost-effective C-arms with rising exports to emerging markets and tier-two hospitals.

Key Financials: 2025 C-Arms revenue US$ 85.00 Million; Strong double-digit growth in exports projected through 2030.
Flagship Products: Allengers HF C-Arm, DigiC-Arm series
2025-2026 Actions: Expanded production capacity, upgraded digital detectors, and built dedicated Africa and Middle East sales teams.
Three-line SWOT: Attractive pricing and responsive local service; Lower brand recognition in developed markets; Opportunity—government-funded hospital programs and private nursing homes in emerging regions.
Notable Customers: Indian state hospitals, Nigerian private hospitals, Bangladeshi surgical centers
9

Medtronic plc (O-arm / imaging segment)

Global medtech major offering intraoperative 3D imaging systems that function as advanced C-arms for spine and neurosurgery.

Key Financials: 2025 C-Arms revenue US$ 80.00 Million; Navigation and robotics-linked imaging revenues growing near 8.10% annually.
Flagship Products: O-arm O2 Imaging System integrated with StealthStation navigation
2025-2026 Actions: Deepened integration with spine robots, launched enhanced navigation workflows, and expanded training centers.
Three-line SWOT: Unique positioning in image-guided spine surgery; Limited presence in general-purpose C-arms; Opportunity—increasing adoption of integrated navigation and robotics in complex surgery.
Notable Customers: Leading spine centers in USA, German university hospitals, Japanese neurosurgical centers
10

Eurocolumbus s.r.l.

Smaller European manufacturer offering customized C-arm solutions tailored to regional surgical and interventional needs.

Key Financials: 2025 C-Arms revenue US$ 45.00 Million; Stable, mid-single-digit growth expected in core European markets.
Flagship Products: Customized mobile C-arms, Eurocolumbus surgical imaging series
2025-2026 Actions: Focused on OEM deals, niche hybrid OR projects, and incremental detector upgrades.
Three-line SWOT: High flexibility and customer-specific engineering; Limited geographic reach and scale; Opportunity—specialized centers seeking bespoke configurations and service responsiveness.
Notable Customers: Regional Italian hospitals, private clinics in Southern Europe, select OEM partners

SWOT Leaders

Siemens Healthineers AG

SWOT Snapshot

SWOT
Strengths

Comprehensive C-arm portfolio, strong hybrid OR presence, advanced AI-enabled imaging, and robust global service infrastructure.

Weaknesses

Premium pricing and complex configurations can slow decisions in mid-tier and cost-constrained hospitals.

Opportunities

Growth in image-guided minimally invasive procedures, robotics-integrated surgery, and large multi-site managed-service contracts.

Threats

Price pressure from Asian vendors, reimbursement constraints, and increasing competition in high-end interventional suites.

GE HealthCare Technologies Inc.

SWOT Snapshot

SWOT
Strengths

Iconic OEC brand, strong U.S. distribution, broad clinical coverage, and solid remote service capabilities.

Weaknesses

Exposure to mature U.S. market cycles and limited ultra-low-cost portfolio for emerging economies.

Opportunities

Rapid ASC expansion, aging installed base replacements, and integration with anesthesia, monitoring, and digital platforms.

Threats

Aggressive regional manufacturers, hospital capital constraints, and evolving radiation safety regulations increasing R&D demands.

Philips Healthcare (Royal Philips)

SWOT Snapshot

SWOT
Strengths

Leadership in interventional cardiology, robust software and informatics ecosystem, and strong European hospital relationships.

Weaknesses

Legacy quality and recall issues have impacted brand perception in some markets recently.

Opportunities

Cloud-connected image-guided therapy platforms, subscription models, and oncology-focused interventional suites expansion.

Threats

Intensifying competition in interventional labs, budget-driven tenders, and macroeconomic uncertainty delaying capital projects.

C-Arms Market Regional Competitive Landscape

North America remains the single largest region for C-arms, with high penetration of mobile systems in hospitals and ambulatory surgery centers. GE HealthCare Technologies Inc. and Siemens Healthineers AG dominate replacement cycles, while Medtronic’s O-arm gains share in complex spine procedures. Capital budgets favor premium flat-panel C-arms with advanced dose management and integrated navigation.

Western Europe shows strong demand for hybrid operating rooms and interventional labs, benefitting Siemens Healthineers AG and Philips Healthcare (Royal Philips). Ziehm Imaging GmbH and Eurocolumbus s.r.l. compete in smaller hospitals and private clinics. Strict radiation regulations and high clinician expectations drive adoption of advanced detectors, 3D imaging, and seamless integration with hospital IT systems.

Asia-Pacific is the fastest-growing region, driven by hospital construction in China, India, and Southeast Asia, and rising surgical volumes. Canon Medical Systems Corporation and Shimadzu Corporation leverage local presence, while Allengers Medical Systems Limited expands from India into neighboring markets. Global C-Arms market companies compete through localized pricing, financing programs, and training initiatives for young surgeons.

Latin America presents a mixed picture, with pockets of high-end demand in Brazil, Mexico, and Chile, alongside budget-constrained public sectors. Siemens Healthineers AG, GE HealthCare Technologies Inc., and Shimadzu Corporation secure major tenders, whereas Allengers Medical Systems Limited gains share via lower-cost digital C-arms. Service coverage and uptime guarantees are decisive differentiators in procurement processes.

In the Middle East and Africa, large projects in Gulf Cooperation Council countries prioritize premium C-arms for flagship hospitals, favoring Siemens Healthineers AG, GE HealthCare Technologies Inc., and Philips Healthcare (Royal Philips). Sub-Saharan Africa, by contrast, is highly price-sensitive, offering opportunities to Allengers Medical Systems Limited and regional distributors that provide rugged, easy-to-maintain systems and turnkey training.

Emerging Eastern European and Central Asian markets are upgrading aging analog C-arms to digital and flat-panel platforms. Ziehm Imaging GmbH and Shimadzu Corporation see traction through competitive pricing and flexible financing. Strong relationships with ministries of health, bundled maintenance contracts, and participation in multilateral-funded hospital projects are key for C-Arms market companies targeting these regions.

C-Arms Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

ImagoX Robotics
Disruptor
USA

Developing compact robotic C-arm platforms with automated positioning and AI-based collision avoidance to streamline workflows in crowded operating rooms.

QuantumDetekt Imaging
Disruptor
Germany

Pioneering next-generation low-dose flat-panel detectors and advanced reconstruction algorithms to significantly reduce radiation exposure without compromising image quality.

SurgiStream HealthTech
Disruptor
India

Cloud-native software layer that retrofits existing C-arms, enabling analytics, remote diagnostics, and pay-per-use models for smaller hospitals and clinics.

Lumica MedSystems
Disruptor
Israel

Integrating augmented reality overlays with C-arm imaging, allowing surgeons to visualize 3D anatomy and implants in real time during minimally invasive procedures.

NeoVue Medical
Disruptor
South Korea

Focusing on ultra-mobile, battery-powered C-arms for outpatient centers and field hospitals, emphasizing portability, rapid setup, and intuitive touchscreen controls.

C-Arms Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning C-Arms market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards C-Armsmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.